Rebuttal to overinterpretation of the antiviral results for human coronavirus 229E relative to severe acute respiratory syndrome coronavirus-2 by Rowpar Pharmaceuticals.
Craig MeyersRichard RobisonJanice MiliciSamina AlamDavid QuillenDavid GoldenbergRena KassPublished in: Journal of medical virology (2021)